{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T07:17:36Z","timestamp":1768202256233,"version":"3.49.0"},"reference-count":26,"publisher":"CSIRO Publishing","issue":"5","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":3261,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12,14]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To explore understanding, perceptions and feelings about meningococcal disease in members of higher risk groups. To explore what people say are the most important health messages and communication preferences about invasive meningococcal disease (IMD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Three focus groups and two semistructured interviews were conducted with people at higher risk of IMD in Hunter New England Local Health District in New South Wales.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Participants generally had a low understanding of IMD, but described intense feelings about the disease and empathy for those who had experienced the disease. Fear of stigma and the impact of stigma were identified. Participants identified reasons for delaying presentation for care as perceptions of invincibility (particularly among young people), the cost of care (for all groups), and racism (particularly for Aboriginal people). These issues were both potential and experienced barriers for participants accessing help when acutely unwell. Factors for effective communication to improve understanding of IMD included the communication being acceptable, accessible and appropriate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>IMD is a serious but uncommon disease that has a range of impacts on people, families and communities. Higher risk groups may benefit from receiving more appropriate and accessible information about early signs and symptoms of IMD. Communication and understanding about the disease could be improved by working with new technologies and partnering with key people in high-risk groups. Use of text messages and social networking for urgent communication could be considered and trialled in public health practice. It is also important to recognise the potential direct or indirect experience of racism and stigma for patients with IMD and their families. Management of IMD could be strengthened by connecting people and families with support groups or services to reduce the impact of the disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.17061\/phrp2651658","type":"journal-article","created":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T00:29:07Z","timestamp":1481588947000},"source":"Crossref","is-referenced-by-count":0,"title":["Describing meningococcal disease: understanding, perceptions and feelings of people in a regional area of NSW, Australia"],"prefix":"10.1071","volume":"26","author":[{"given":"Julie","family":"Kohlhagen","sequence":"first","affiliation":[{"name":"A Hunter New England Population Health, Newcastle, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Massey","sequence":"additional","affiliation":[{"name":"B Hunter New England Population Health, Tamworth, NSW Australia"},{"name":"C College of Medicine and Dentistry, James Cook University, Townsville, QLD, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kylie","family":"Taylor","sequence":"additional","affiliation":[{"name":"D Hunter New England Public Health, Tamworth, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maggi","family":"Osbourn","sequence":"additional","affiliation":[{"name":"E Hunter New England Public Health, Newcastle, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myfanwy","family":"Maple","sequence":"additional","affiliation":[{"name":"F School of Health, University of New England, Armidale, NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"67","published-online":{"date-parts":[[2016,12,14]]},"reference":[{"key":"2026011123113746100_R1","unstructured":"Mandell G, Bennett J, Dolin R. Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 7th edition. Philadelphia, PA: Churchill Livingstone Elsevier, 2010."},{"key":"2026011123113746100_R2","doi-asserted-by":"crossref","unstructured":"Haines C. Parents' experiences of living through their child's suffering from and surviving severe meningococcal disease. Nurs Crit Care. 2005;10(2):78\u201389. CrossRef | PubMed","DOI":"10.1111\/j.1362-1017.2005.00080.x"},{"key":"2026011123113746100_R3","unstructured":"NNDSS Annual Report Writing Group. Australia\u2019s notifiable disease status, 2014: annual report of the National Notifiable Diseases Surveillance System. Canberra: Australian Government Department of Health; 2014 [cited 2016 Nov 1] Available from: www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/cda-pubs-annlrpt-nndssar.htm"},{"key":"2026011123113746100_R4","doi-asserted-by":"crossref","unstructured":"Massey P, Durrheim D. Aboriginal and Torres Strait Islander peoples at higher risk of invasive meningococcal disease in NSW. N S W Public Health Bull. 2008;19(5\u20136):100\u20133. CrossRef | PubMed","DOI":"10.1071\/NB07047"},{"key":"2026011123113746100_R5","doi-asserted-by":"crossref","unstructured":"Naidu L, Chiu C, Habig A, Lowbridge C, Jayasinghe S, Wang H, et al. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006\u20132010. Commun Dis Intel Q Rep. 2013;37 Suppl:S1\u201395. PubMed","DOI":"10.33321\/cdi.2013.37.64"},{"key":"2026011123113746100_R6","doi-asserted-by":"crossref","unstructured":"Lahra M, Enriquez R. Annual report of the Australian Meningococcal Surveillance Programme, 2011. Commun Dis Intell. 2012;36(3):E251\u201362. PubMed","DOI":"10.33321\/cdi.2012.36.19"},{"key":"2026011123113746100_R7","unstructured":"Communicable Diseases Network of Australia. Invasive meningococcal disease CDNA national guidelines for public health units. Canberra: Australian Government Department of Health; 2014 [cited 2016 Oct 18]. Available from: www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/0A31EEC4953B7E6FCA257DA3000D19DD\/$File\/IMD-1.1-april2015.pdf"},{"key":"2026011123113746100_R8","doi-asserted-by":"crossref","unstructured":"Cartwright K, Strang J, Gossain S, Begg N. Early treatment of meningococcal disease [letter]. BMJ. 1992;305(6856):774. CrossRef | PubMed","DOI":"10.1136\/bmj.305.6856.774"},{"key":"2026011123113746100_R9","unstructured":"9.Sofaer S. Qualitative methods: what are they and why use them? Health Serv Res. 1999;34(5 Pt 2):1101\u201318. PubMed"},{"key":"2026011123113746100_R10","doi-asserted-by":"crossref","unstructured":"Glaser BG, Strauss AL. The discovery of grounded theory: strategies for qualitative research. New York: Aldine Publishing Company; 1967.","DOI":"10.1097\/00006199-196807000-00014"},{"key":"2026011123113746100_R11","unstructured":"Strauss A, Corbin J. Basics of qualitative research: grounded theory procedures and technique. Newbury Park, CA: Sage; 1998."},{"key":"2026011123113746100_R12","unstructured":"Lee T. Using qualitative methods in organizational research. Thousand Oaks, CA: Sage; 1999."},{"key":"2026011123113746100_R13","doi-asserted-by":"crossref","unstructured":"Faber ESL, Delaney AJ, Power JM, Sedlak PL, Crane JW, Sah P. Modulation of SK channel trafficking by beta adrenoceptors enhances excitatory synaptic transmission and the plasticity in the amygdala. J Neurosci. 2008;28(43):10803\u201313. CrossRef | PubMed","DOI":"10.1523\/JNEUROSCI.1796-08.2008"},{"key":"2026011123113746100_R14","doi-asserted-by":"crossref","unstructured":"Borg J, Christie D, Coen P, Booy R, Viner RM. Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study. Paediatrics. 2009;123(3):e502\u20139. CrossRef | PubMed","DOI":"10.1542\/peds.2008-0581"},{"key":"2026011123113746100_R15","doi-asserted-by":"crossref","unstructured":"Sweeney F, Viner RM, Booy R, Christie D. Parents\u2019 experiences of support during and after their child\u2019s diagnosis of meningococcal disease. Acta Paediatr. 2013;102(3):e126\u201330. CrossRef | PubMed","DOI":"10.1111\/apa.12112"},{"key":"2026011123113746100_R16","doi-asserted-by":"crossref","unstructured":"16.Wang B, Clarke M, Afzali HH, Marshall H. Community, parental and adolescent awareness and knowledge of meningococcal disease. Vaccine. 2014;32:(18)2042\u20139. CrossRef | PubMed","DOI":"10.1016\/j.vaccine.2014.02.054"},{"key":"2026011123113746100_R17","doi-asserted-by":"crossref","unstructured":"Kai J. What worries parents when their preschool children are acutely ill, and why: a qualitative study. BMJ. 1996;(31397063):983\u20136. CrossRef | PubMed","DOI":"10.1136\/bmj.313.7063.983"},{"key":"2026011123113746100_R18","doi-asserted-by":"crossref","unstructured":"Larson A, Gillies M, Howard PJ, Coffin J. It's enough to make you sick: the impact of racism on the health of Aboriginal Australians. Aust N Z J Public Health. 2007;31(4):322\u20139. CrossRef | PubMed","DOI":"10.1111\/j.1753-6405.2007.00079.x"},{"key":"2026011123113746100_R19","unstructured":"COAG Reform Council. Healthcare 2010\u201311: comparing performance across Australia. Sydney: COAG Reform Council; 2012 [cited 2016 Oct 18]. Available from: https:\/\/library.bsl.org.au\/jspui\/bitstream\/1\/3188\/1\/Healthcare_2010-11-Full_report.pdf"},{"key":"2026011123113746100_R20","doi-asserted-by":"crossref","unstructured":"Butt G, Paterson B, McGuinness L. Living with the stigma of hepatitis C. West J Nurs Res. 2008;30(2):204\u201321. CrossRef | PubMed","DOI":"10.1177\/0193945907302771"},{"key":"2026011123113746100_R21","doi-asserted-by":"crossref","unstructured":"Barroso J, Powell-Cope G. Metasynthesis of qualitative research on living with HIV infection. Qual Health Res.2000;10(3):340\u201353. CrossRef | PubMed","DOI":"10.1177\/104973200129118480"},{"key":"2026011123113746100_R22","doi-asserted-by":"crossref","unstructured":"Williams J, Gonzalez-Medina D, Le Q. Infectious diseases and social stigma. ATI. 2011;4(1):58\u201370. Article","DOI":"10.15208\/ati.2011.7"},{"key":"2026011123113746100_R23","doi-asserted-by":"crossref","unstructured":"23.Courtwright A and Norris Turner A. Tuberculosis and stigmatization: pathways and interventions. Public Health Rep. 2010:125 Suppl 4:34\u201342. PubMed","DOI":"10.1177\/00333549101250S407"},{"key":"2026011123113746100_R24","unstructured":"Australian Institute of Health and Welfare. The health and welfare of Australia\u2019s Aboriginal and Torres Strait Islander people, an overview. Canberra: AIHW; 2011 [cited 2016 Oct 18]. Available from: www.aihw.gov.au\/WorkArea\/DownloadAsset.aspx?id=10737418955"},{"key":"2026011123113746100_R25","doi-asserted-by":"crossref","unstructured":"Henry B, Houston S, Mooney G. Institutional racism in Australian healthcare: a plea for decency. Med J Aust. 2004;180(10):517\u201320. PubMed","DOI":"10.5694\/j.1326-5377.2004.tb06056.x"},{"key":"2026011123113746100_R26","doi-asserted-by":"crossref","unstructured":"Massey PD, Pearce G, Taylor KT, Orcher L, Saggers S, Durrheim DN. Reducing the risk of pandemic influenza in Aboriginal communities. Rural Remote Health.2009;9(3):1290. PubMed","DOI":"10.22605\/RRH1290"}],"container-title":["Public Health Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/pu\/article-pdf\/doi\/10.17061\/phrp2651658\/1821961\/pu19111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/pu\/article-pdf\/doi\/10.17061\/phrp2651658\/1821961\/pu19111.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T04:11:50Z","timestamp":1768191110000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/pu\/article\/26\/5\/e2651658\/265325\/Describing-meningococcal-disease-understanding"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,14]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,12,14]]}},"URL":"https:\/\/doi.org\/10.17061\/phrp2651658","relation":{},"ISSN":["2204-2091"],"issn-type":[{"value":"2204-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,14]]},"article-number":"e2651658"}}